| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $109.6M | +125.4% |
| Cost of Revenue | $71.7M | +177.1% |
| Gross Profit | $37.9M | +66.5% |
| R&D Expense | $5.4M | -31.3% |
| SG&A Expense | $15.6M | +13.5% |
| Operating Income | $1.4M | +109.0% |
| Pre-tax Income | $1.6M | +109.5% |
| Net Income | $1.5M | +108.9% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.4M | +161.8% |
| Short-term Investments | $2K | +0.0% |
| Accounts Receivable | $1.1M | -61.1% |
| Current Assets | $30.4M | +106.6% |
| Total Assets | $71.4M | +36.0% |
| Current Liabilities | $14.8M | +45.4% |
| Total Liabilities | $14.8M | +45.4% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $12.3M | +387.3% |
| Capital Expenditures | $12K | -47.5% |
| Investing Cash Flow | $1.5M | +623.3% |
| Financing Cash Flow | $3.8M | +67.9% |
| Free Cash Flow | $12.3M | +385.6% |
| $56.6M |
| +33.8% |